Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1 A Cerani, N Tetreault, C Menard, E Lapalme, C Patel, N Sitaras, ... Cell metabolism 18 (4), 505-518, 2013 | 152 | 2013 |
Neuronal ER stress impedes myeloid-cell-induced vascular regeneration through IRE1α degradation of netrin-1 F Binet, G Mawambo, N Sitaras, N Tetreault, E Lapalme, S Favret, ... Cell metabolism 17 (3), 353-371, 2013 | 91 | 2013 |
Do estrogens impact adolescent idiopathic scoliosis? D Leboeuf, K Letellier, N Alos, P Edery, F Moldovan Trends in Endocrinology & Metabolism 20 (4), 147-152, 2009 | 87 | 2009 |
Computationally guided high-throughput design of self-assembling drug nanoparticles D Reker, Y Rybakova, AR Kirtane, R Cao, JW Yang, N Navamajiti, ... Nature nanotechnology 16 (6), 725-733, 2021 | 71 | 2021 |
Deficiency in the metabolite receptor SUCNR1 (GPR91) leads to outer retinal lesions S Favret, F Binet, E Lapalme, D Leboeuf, J Carbadillo, T Rubic, E Picard, ... Aging (Albany NY) 5 (6), 427, 2013 | 40 | 2013 |
lncRNA in the liver: Prospects for fundamental research and therapy by RNA interference EM Smekalova, YV Kotelevtsev, D Leboeuf, EY Shcherbinina, AS Fefilova, ... Biochimie 131, 159-172, 2016 | 35 | 2016 |
TCR triggering modulates the responsiveness and homeostatic proliferation of CD4+ thymic emigrants to IL-7 therapy O Hennion-Tscheltzoff, D Leboeuf, SD Gauthier, M Dupuis, B Assouline, ... Blood 121 (23), 4684-4693, 2013 | 24 | 2013 |
Downregulation of the Arg/N-degron pathway sensitizes cancer cells to chemotherapy in vivo D Leboeuf, T Abakumova, T Prikazchikova, L Rhym, DG Anderson, ... Molecular therapy 28 (4), 1092-1104, 2020 | 23 | 2020 |
Homeostatic cytokines in immune reconstitution and graft-versus-host disease S Thiant, MM Moutuou, D Leboeuf, M Guimond Cytokine 82, 24-32, 2016 | 20 | 2016 |
Evaluation of cytosine base editing and adenine base editing as a potential treatment for alpha-1 antitrypsin deficiency MS Packer, V Chowdhary, G Lung, LI Cheng, Y Aratyn-Schaus, ... Molecular Therapy 30 (4), 1396-1406, 2022 | 18 | 2022 |
Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4+ T Cells after Allogeneic Stem Cell Transplantation SD Gauthier, D Leboeuf, R Manuguerra-Gagné, L Gaboury, M Guimond Biology of Blood and Marrow Transplantation 21 (10), 1721-1731, 2015 | 17 | 2015 |
Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients S Thiant, MM Moutuou, P Laflamme, RS Boumedine, DM Leboeuf, ... Blood cancer journal 7 (4), e551, 2017 | 13 | 2017 |
IL-7 Is the Limiting Homeostatic Factor that Constrains Homeostatic Proliferation of CD8+ T Cells after Allogeneic Stem Cell Transplantation and Graft-versus-Host Disease SD Gauthier, MM Moutuou, F Daudelin, D Leboeuf, M Guimond Biology of Blood and Marrow Transplantation 25 (4), 648-655, 2019 | 9 | 2019 |
The Arg/N-Degron Pathway—A Potential Running Back in Fine-Tuning the Inflammatory Response? D Leboeuf, M Pyatkov, TS Zatsepin, K Piatkov Biomolecules 10 (6), 903, 2020 | 7 | 2020 |
Cytosine base editing inhibits Hepatitis B Virus replication and reduces HBsAg expression in vitro and in vivo E Smekalova, MG Martinez, E Combe, S Dejene, M Packer, D LeBoeuf, ... | 4* | |
Novel Apoptotic Mediators Identified by Conservation of Vertebrate Caspase Targets N Gubina, D Leboeuf, K Piatkov, M Pyatkov Biomolecules 10 (4), 612, 2020 | 3 | 2020 |
Studying Peripheral T Cell Homeostasis in Mice: A Concise Technical Review MM Moutuou, SD Gauthier, N Chen, D Leboeuf, M Guimond T-Cell Receptor Signaling: Methods and Protocols, 267-283, 2020 | 2 | 2020 |
Ubiquitin ligases: a new target for RNAi therapy of hepatocellular carcinoma D Leboeuf, T Zatsepin, DG Anderson, K Piatkov Cancer Research 77 (13_Supplement), 3131-3131, 2017 | 1 | 2017 |
Optimized Base Editing Reagents Yield More Potent Genetic Correction in a Mouse Model of Alpha-1 Antitrypsin Deficiency MS Packer, D Leboeuf, LI Cheng, R Yang, J Decker, M Otero, LA Barrera, ... MOLECULAR THERAPY 30 (4), 117-118, 2022 | | 2022 |
Single, Systemic Administration of BEAM-301 Mitigates Fasting Hypoglycemia and Restores Metabolic Function in a Transgenic Mouse Model of Glycogen Storage Disease Type Ia Y Aratyn-Schaus, I Arnaoutova, D Leboeuf, TP Fernandez, T Leete, ... MOLECULAR THERAPY 30 (4), 42-43, 2022 | | 2022 |